Whether pioglitazone

Whether pioglitazone may affect breast cancer risk in female diabetes patients is not conclusive and has not been investigated in the Asian populations. This study suggests a null association between pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus.

11p viangelamerkel 27-07-2022 6 3   Download

Whether pioglitazone (PIO), a peroxisome proliferator-activated receptor-gamma agonist, increases the risk of developing bladder cancer has been debated for several years. The aim of this study was to investigate the in vitro effects of PIO on normal urothelial transitional epithelium (NUTE) cells and bladder cancer (J82) cells to further evaluate the risk.

10p vinasaki2711 12-11-2019 14 1   Download